Clinical Trial Update: Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating interleukin-2 in patients with active warm autoimmune hemolytic anemia resistant to conventional treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Autoimmune Hemolytic Anemia | Phase 1, Phase 2 | Status: COMPLETED